By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoViricides, Inc. 

135 Wood Street, Suite 205

West Haven  Connecticut  06516  U.S.A.
Phone: n/a Fax:


Company News
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2015-03-31 5/18/2015 10:28:15 AM
NanoViricides, Inc. (NNVC.PK) Discusses The Strong Effectiveness Of Its Anti-Herpes Drug Candidates In A Lethal Animal Model Of Dermal Herpes Infection 4/27/2015 10:30:43 AM
NanoViricides, Inc. (NNVC.PK) Reports That Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms In An Animal Model 4/20/2015 10:36:20 AM
NanoViricides, Inc. (NNVC.PK) Provides An Update On Its Progress Over The Last Quarter 4/6/2015 9:56:43 AM
NanoViricides, Inc. (NNVC.PK) Issued Registered Shares As Interest To Certain Debenture Holders 3/9/2015 7:00:01 AM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2014-12-31 2/25/2015 9:35:31 AM
NanoViricides, Inc. (NNVC.PK) Announces That A Research Report On The Company Has Been Published By Midtown Partners, Inc., A New York Investment Bank 2/17/2015 1:13:17 PM
NanoViricides, Inc. (NNVC.PK) Reports That The FluCide™ Candidate Was Found To Be Very Safe In Cglp-Like Safety And Toxicology Study In Rats Performed By Basi 1/23/2015 10:12:47 AM
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015 10:24:46 AM
NanoViricides, Inc. (NNVC.PK)'s Executive Officers Report Insider Purchases Of Common Stock 1/21/2015 8:19:02 AM